Top
Pouring petrol on the flames:
Using oncolytic virotherapies to enhance tumour immunogenicity
Pouring petrol on the flames:
Using oncolytic virotherapies to enhance tumour immunogenicity
DOI: 10.1111/imm.13323, Volume: 163, Issue: 4, Pages: 389-398
Article Type: review-article,
Article History
received:
accepted:
published:
-
-
-
- Altmetric
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.1111/imm.13323&title=Pouring petrol on the flames:
Using oncolytic virotherapies to enhance tumour immunogenicity&author=&keyword=[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=266280}, {keywordId=8263, uniqueName=antibodies, name=Antibodies, contentId=266280}, {keywordId=41638, uniqueName=oncolytic-viruses, name=oncolytic viruses, contentId=266280}, {keywordId=58387, uniqueName=model-systems, name=model systems, contentId=266280}, {keywordId=78165, uniqueName=virotherapy, name=Virotherapy, contentId=266280}, {keywordId=328252, uniqueName=car-
t-cells, last=true, name=CAR
T cells, contentId=266280}],[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=266280}, {keywordId=8263, uniqueName=antibodies, name=Antibodies, contentId=266280}, {keywordId=41638, uniqueName=oncolytic-viruses, name=oncolytic viruses, contentId=266280}, {keywordId=58387, uniqueName=model-systems, name=model systems, contentId=266280}, {keywordId=78165, uniqueName=virotherapy, name=Virotherapy, contentId=266280}, {keywordId=328252, uniqueName=car-
t-cells, last=true, name=CAR
T cells, contentId=266280}],[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=266280}, {keywordId=8263, uniqueName=antibodies, name=Antibodies, contentId=266280}, {keywordId=41638, uniqueName=oncolytic-viruses, name=oncolytic viruses, contentId=266280}, {keywordId=58387, uniqueName=model-systems, name=model systems, contentId=266280}, {keywordId=78165, uniqueName=virotherapy, name=Virotherapy, contentId=266280}, {keywordId=328252, uniqueName=car-
t-cells, last=true, name=CAR
T cells, contentId=266280}],[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=266280}, {keywordId=8263, uniqueName=antibodies, name=Antibodies, contentId=266280}, {keywordId=41638, uniqueName=oncolytic-viruses, name=oncolytic viruses, contentId=266280}, {keywordId=58387, uniqueName=model-systems, name=model systems, contentId=266280}, {keywordId=78165, uniqueName=virotherapy, name=Virotherapy, contentId=266280}, {keywordId=328252, uniqueName=car-
t-cells, last=true, name=CAR
T cells, contentId=266280}],[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=266280}, {keywordId=8263, uniqueName=antibodies, name=Antibodies, contentId=266280}, {keywordId=41638, uniqueName=oncolytic-viruses, name=oncolytic viruses, contentId=266280}, {keywordId=58387, uniqueName=model-systems, name=model systems, contentId=266280}, {keywordId=78165, uniqueName=virotherapy, name=Virotherapy, contentId=266280}, {keywordId=328252, uniqueName=car-
t-cells, last=true, name=CAR
T cells, contentId=266280}],[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=266280}, {keywordId=8263, uniqueName=antibodies, name=Antibodies, contentId=266280}, {keywordId=41638, uniqueName=oncolytic-viruses, name=oncolytic viruses, contentId=266280}, {keywordId=58387, uniqueName=model-systems, name=model systems, contentId=266280}, {keywordId=78165, uniqueName=virotherapy, name=Virotherapy, contentId=266280}, {keywordId=328252, uniqueName=car-
t-cells, last=true, name=CAR
T cells, contentId=266280}],&subject=
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy | Powered by: Nova